|
Volumn 33, Issue 1-2, 2001, Pages 1945-1947
|
Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2
a a a a a a a,b a,b a,c |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMMONIA;
GLUTAMATE AMMONIA LIGASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTIFICIAL LIVER;
BIOREACTOR;
BLOOD CLOTTING;
CELL STRAIN HEPG2;
CONFERENCE PAPER;
CONTROLLED STUDY;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
LIVER CELL;
LIVER FAILURE;
LIVER ISCHEMIA;
NONHUMAN;
PRIORITY JOURNAL;
SURVIVAL;
SWINE;
ANIMALS;
CELL LINE;
CELL SURVIVAL;
GLUTAMATE-AMMONIA LIGASE;
HEPATOCYTES;
ISCHEMIA;
LIVER;
LIVER FAILURE;
LIVER, ARTIFICIAL;
SWINE;
TIME FACTORS;
TRANSFECTION;
|
EID: 0035080997
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)02722-6 Document Type: Article |
Times cited : (19)
|
References (10)
|